These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
585 related articles for article (PubMed ID: 33568752)
21. Inhibition of advance glycation end products formation, gastrointestinal digestion, absorption and toxicity: A comprehensive review. Feng N; Feng Y; Tan J; Zhou C; Xu J; Chen Y; Xiao J; He Y; Wang C; Zhou M; Wu Q Int J Biol Macromol; 2023 Sep; 249():125814. PubMed ID: 37451379 [TBL] [Abstract][Full Text] [Related]
22. Revisiting Methodologies for In Vitro Preparations of Advanced Glycation End Products. Sahi AK; Verma P; Varshney N; Gundu S; Mahto SK Appl Biochem Biotechnol; 2022 Jun; 194(6):2831-2855. PubMed ID: 35257316 [TBL] [Abstract][Full Text] [Related]
23. Identifying advanced glycation end products as a major source of oxidants in aging: implications for the management and/or prevention of reduced renal function in elderly persons. Vlassara H; Uribarri J; Ferrucci L; Cai W; Torreggiani M; Post JB; Zheng F; Striker GE Semin Nephrol; 2009 Nov; 29(6):594-603. PubMed ID: 20006791 [TBL] [Abstract][Full Text] [Related]
24. Advanced glycation end products and RAGE: a common thread in aging, diabetes, neurodegeneration, and inflammation. Ramasamy R; Vannucci SJ; Yan SS; Herold K; Yan SF; Schmidt AM Glycobiology; 2005 Jul; 15(7):16R-28R. PubMed ID: 15764591 [TBL] [Abstract][Full Text] [Related]
25. Cellular mechanisms and consequences of glycation in atherosclerosis and obesity. López-Díez R; Shekhtman A; Ramasamy R; Schmidt AM Biochim Biophys Acta; 2016 Dec; 1862(12):2244-2252. PubMed ID: 27166197 [TBL] [Abstract][Full Text] [Related]
26. Age-related accumulation of advanced glycation end-products-albumin, S100β, and the expressions of advanced glycation end product receptor differ in visceral and subcutaneous fat. Son KH; Son M; Ahn H; Oh S; Yum Y; Choi CH; Park KY; Byun K Biochem Biophys Res Commun; 2016 Aug; 477(2):271-6. PubMed ID: 27301641 [TBL] [Abstract][Full Text] [Related]
27. Advanced glycation end products in musculoskeletal system and disorders. Suzuki A; Yabu A; Nakamura H Methods; 2022 Jul; 203():179-186. PubMed ID: 32987130 [TBL] [Abstract][Full Text] [Related]
28. Advanced Glycation End Products: Association with the Pathogenesis of Diseases and the Current Therapeutic Advances. Ajith TA; Vinodkumar P Curr Clin Pharmacol; 2016; 11(2):118-27. PubMed ID: 27164965 [TBL] [Abstract][Full Text] [Related]
29. Advanced glycation end-products produced systemically and by macrophages: A common contributor to inflammation and degenerative diseases. Byun K; Yoo Y; Son M; Lee J; Jeong GB; Park YM; Salekdeh GH; Lee B Pharmacol Ther; 2017 Sep; 177():44-55. PubMed ID: 28223234 [TBL] [Abstract][Full Text] [Related]
30. Pathologic role of dietary advanced glycation end products in cardiometabolic disorders, and therapeutic intervention. Yamagishi S; Matsui T Nutrition; 2016 Feb; 32(2):157-65. PubMed ID: 26602289 [TBL] [Abstract][Full Text] [Related]
31. Glycation reaction and the role of the receptor for advanced glycation end-products in immunity and social behavior. Leerach N; Harashima A; Munesue S; Kimura K; Oshima Y; Goto H; Yamamoto H; Higashida H; Yamamoto Y Glycoconj J; 2021 Jun; 38(3):303-310. PubMed ID: 33108607 [TBL] [Abstract][Full Text] [Related]
32. Experimental Animal Studies Support the Role of Dietary Advanced Glycation End Products in Health and Disease. Peppa M; Mavroeidi I Nutrients; 2021 Sep; 13(10):. PubMed ID: 34684468 [TBL] [Abstract][Full Text] [Related]
33. Phytochemicals as Potential Inhibitors of Advanced Glycation End Products: Health Aspects and Patent Survey. Fernandes ACF; Melo JB; Genova VM; Santana ÁL; Macedo G Recent Adv Food Nutr Agric; 2022 Nov; 13(1):3-16. PubMed ID: 34053432 [TBL] [Abstract][Full Text] [Related]
34. An insight on the association of glycation with hepatocellular carcinoma. Jabir NR; Ahmad S; Tabrez S Semin Cancer Biol; 2018 Apr; 49():56-63. PubMed ID: 28634055 [TBL] [Abstract][Full Text] [Related]
35. Impact of Advanced Glycation End products (AGEs) and its receptor (RAGE) on cancer metabolic signaling pathways and its progression. Muthyalaiah YS; Jonnalagadda B; John CM; Arockiasamy S Glycoconj J; 2021 Dec; 38(6):717-734. PubMed ID: 35064413 [TBL] [Abstract][Full Text] [Related]
36. Extracellular matrix glycation and receptor for advanced glycation end-products activation: a missing piece in the puzzle of the association between diabetes and cancer. Rojas A; Añazco C; González I; Araya P Carcinogenesis; 2018 Apr; 39(4):515-521. PubMed ID: 29373651 [TBL] [Abstract][Full Text] [Related]
37. Advanced Glycation End Products and Diabetes Mellitus: Mechanisms and Perspectives. Khalid M; Petroianu G; Adem A Biomolecules; 2022 Apr; 12(4):. PubMed ID: 35454131 [TBL] [Abstract][Full Text] [Related]
38. Differential contribution of possible pattern-recognition receptors to advanced glycation end product-induced cellular responses in macrophage-like RAW264.7 cells. Watanabe M; Toyomura T; Wake H; Liu K; Teshigawara K; Takahashi H; Nishibori M; Mori S Biotechnol Appl Biochem; 2020 Mar; 67(2):265-272. PubMed ID: 31654427 [TBL] [Abstract][Full Text] [Related]
39. Advanced Glycation End Products: A Sweet Flavor That Embitters Cardiovascular Disease. Pinto RS; Minanni CA; de Araújo Lira AL; Passarelli M Int J Mol Sci; 2022 Feb; 23(5):. PubMed ID: 35269546 [TBL] [Abstract][Full Text] [Related]
40. Advanced Glycation End Products: Potential Mechanism and Therapeutic Target in Cardiovascular Complications under Diabetes. Yang P; Feng J; Peng Q; Liu X; Fan Z Oxid Med Cell Longev; 2019; 2019():9570616. PubMed ID: 31885827 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]